Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma.
Ann Oncol. 2015 Jul;26(7):1378-84. doi: 10.1093/annonc/mdv170. Epub 2015 Apr 7.
Ann Oncol. 2015.
PMID: 25851632
Free article.
Clinical Trial.
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, Voi M, Peyrard S, Pelov D, Franz DN.
French JA, et al. Among authors: pelov d.
Lancet. 2016 Oct 29;388(10056):2153-2163. doi: 10.1016/S0140-6736(16)31419-2. Epub 2016 Sep 6.
Lancet. 2016.
PMID: 27613521
Free article.
Clinical Trial.
Item in Clipboard
Adjunctive everolimus therapy for tuberous sclerosis complex-associated refractory seizures: Results from the postextension phase of EXIST-3.
Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Herbst F, Peyrard S, Pelov D, French JA.
Franz DN, et al. Among authors: pelov d.
Epilepsia. 2021 Dec;62(12):3029-3041. doi: 10.1111/epi.17099. Epub 2021 Oct 25.
Epilepsia. 2021.
PMID: 34693520
Item in Clipboard
Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial.
Curatolo P, Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, de Vries PJ, Dlugos DJ, Fan J, Ridolfi A, Pelov D, Voi M, French JA.
Curatolo P, et al. Among authors: pelov d.
Lancet Child Adolesc Health. 2018 Jul;2(7):495-504. doi: 10.1016/S2352-4642(18)30099-3. Epub 2018 May 24.
Lancet Child Adolesc Health. 2018.
PMID: 30169322
Clinical Trial.
Item in Clipboard
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial.
Franz DN, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Voi M, Fan J, Vaury A, Pelov D, French JA.
Franz DN, et al. Among authors: pelov d.
Neurol Clin Pract. 2018 Oct;8(5):412-420. doi: 10.1212/CPJ.0000000000000514.
Neurol Clin Pract. 2018.
PMID: 30564495
Free PMC article.
Item in Clipboard
Cite
Cite